These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 1701315

  • 21. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW, Vujcic LK, Glass WL, Seamon KB, Rastogi SC, Hendry RM, Boulos R, Nzila N, Quinnan GV.
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [Abstract] [Full Text] [Related]

  • 22. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
    Ugen KE, Goedert JJ, Boyer J, Refaeli Y, Frank I, Williams WV, Willoughby A, Landesman S, Mendez H, Rubinstein A.
    J Clin Invest; 1992 Jun; 89(6):1923-30. PubMed ID: 1601999
    [Abstract] [Full Text] [Related]

  • 23. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
    Turbica I, Simon F, Besnier JM, LeJeune B, Choutet P, Goudeau A, Barin F.
    J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies.
    Laal S, Burda S, Gorny MK, Karwowska S, Buchbinder A, Zolla-Pazner S.
    J Virol; 1994 Jun; 68(6):4001-8. PubMed ID: 7514683
    [Abstract] [Full Text] [Related]

  • 27. Compartmentalization of the IgG immune response to HIV-1 in breast milk.
    Becquart P, Hocini H, Garin B, Sépou A, Kazatchkine MD, Bélec L.
    AIDS; 1999 Jul 30; 13(11):1323-31. PubMed ID: 10449284
    [Abstract] [Full Text] [Related]

  • 28. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
    Hernández M, Pozo L, Gómez I, Melchor A.
    Biochem Biophys Res Commun; 2000 May 27; 272(1):259-62. PubMed ID: 10872836
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation.
    Tian H, Xiao Y, Qin L, Chen YH.
    Immunobiology; 2001 Dec 27; 204(4):434-41. PubMed ID: 11776398
    [Abstract] [Full Text] [Related]

  • 32. [Towards a vaccine against HIV: antibodies raised by a gp41 peptide neutralize the virus and inhibit pathogenesis].
    Vieillard V, Debré P.
    Biol Aujourdhui; 2015 Dec 27; 209(2):161-6. PubMed ID: 26514385
    [Abstract] [Full Text] [Related]

  • 33. Maternal antibodies to HIV-1 envelope domains: No correlation with HIV-1 vertical transmission in patients from Argentina.
    Calarota SA, Libonatti OV.
    Scand J Immunol; 2000 Sep 27; 52(3):292-7. PubMed ID: 10972906
    [Abstract] [Full Text] [Related]

  • 34. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.
    Robertson CA, Mok JY, Froebel KS, Simmonds P, Burns SM, Marsden HS, Graham S.
    J Infect Dis; 1992 Oct 27; 166(4):704-9. PubMed ID: 1527406
    [Abstract] [Full Text] [Related]

  • 35. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F, Vullo V, Cirelli A, Catania S, Mastroianni CM, Contini C, Delia S.
    Boll Ist Sieroter Milan; 1989 Oct 27; 68(2):115-21. PubMed ID: 2562362
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Candidate multi-epitope vaccines in aluminium adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1.
    Ding J, Lu Y, Chen Y.
    FEMS Immunol Med Microbiol; 2000 Oct 27; 29(2):123-7. PubMed ID: 11024351
    [Abstract] [Full Text] [Related]

  • 38. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.
    Chang SY, Vithayasai V, Vithayasai P, Essex M, Lee TH.
    J Infect Dis; 2000 Aug 27; 182(2):442-50. PubMed ID: 10915074
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.